WO2011091807A1 - Anticoagulant and glutathione for treatment of cancer - Google Patents

Abstract

The cancer may treated by using of anticoagulant medications as warrfarine to consume as most as possible of cytochrome P450s and then, administration of glutathione in specific doses to consume the remaining of cytochrome P 450s in replacement of supplying the malignant compound. The patient will be hosted in isolated stabilized room with medical attention because of the side effect of the applied medications.

Description

ANTICOAGULANT AND GLUTATHIONE FOR TREATMENT OF CANCER

Technical Field :

To begin with my medical research are consist of so many corners that we most know the edges of it.

Simply, I discovered which I believe in some how, the cure of cancer, or even to dilute the distribution of it cross certain tissues leading to their damage and elimination.

The main principle that we dealing with, is how do we join the ideas with caution and prevent any fatal mistakes that may occur during the whole period of examination and testing. Specially, on clinical applications.

Background Art :

Most of the medical researches that runs nowadays are about how to identify the gen in the nucleus that is responsible for the presence and initiation of malignancy.

So, the target is how to clear and heal by a certain treatment or medication the hereditary diseases of cancer.

So, the genetic researches is the most abundant field in the medical cancer researches.

Disclosure of invention :

The xenobiotices are substances parallel to the foreign bodies in the meaning from the side of attacking mechanism to the human certain organs, which well be delayed and destroyed by the defense mechanism and immune system as one of the most important vital processes occurring continuously thousand of times at human system.

Cytochrome P450s are immunity workers which work at two completely deferent directions and opposite benefits. - Specific way from general malignancy starting substances :

There is numerous ways that may stimulate the starting of malignant compound.

For example, eating of half cooked liver, will may lead to non completed digestion of hepatic proteins and absorption of many amino acids attached together by poly peptide chains into circulation may occur.

The immunity system will deal with them as foreign bodies because the body doesn't recognize any protein except when it destructed into amino acids.

If two amino acids attached and absorbed into circulation will lead to antigen antibody reaction.

In some cases, the undifferentiated stem cells may mutate according to the genetic code of those amino acids resulting in increasing amount of cells acting exactly the same action of those amino acids.

The protein may binds to cytochrome p450s without the attachment of glutathione to this complex ( look at the details in the next subtitle ).

If these xenopiotic cytochrome complex bind to a tissue of certain organ, mutation may occur resulting in cancer.

For example, if this mutation occurs in skin, will lead to conversion of the parahydroxy group present in the components of ( Tyrosine ) which are normal chemical substance present in skin, into an active hydroxy group_ the inactive OH of tyrosine will be activated _as soon as this action started, malignant is present.

- Normal influences with normal reactions :

The planning pathway of the war zone beginning from entering the body terminal to their destruction is as next :

At normal conditions, xenobiotic bodies enter the body and they will be hosted by cytochrome P450s to be converted to reactive metabolites which will bind as soon as possible with glutathione ( which are normal bodies present in blood and is secreted from liver ) which will convert the xenobiotics cytochrome complex to non toxic material and harmless to the body by the excretion of this complex with glutathione in urine.

- Normal influences with abnormal reactions :

In abnormal conditions, the reactive metabolites may not find glutathione fast enough, leading to covalent binding to substances such as macromolecules, this new unwanted complex will swim in the body till they find a proper organ to start their activation in, and the end result will be destiny according to unknown reasons yet !.

The Final Results :

The result will be nothing but three, to produce cell injury directly, binding with a substance called hapten which will produces also cell injury, or activation of mutation process leading to formation of malignancy.

After we knew the mechanism and the origin of the malignant formation and growth, we may now guess the cure.

- The suggested medical care and medications :

In isolated stabilized room with medical attention, we will place the patient with extremely caution because of the side effect of the suggested medications.

A medical information says that the anticoagulant medication exhausts the cytochrome P450s leading to their consumption. So, we will use warrfarine as one of the anticoagulant medications to make the cytochrome P450s busy with it in replacement of supplying the malignant compounds.

So, administration of warrfarine will be necessary. Then , intake of large doses of glutathione complex to consume the remaining of the xenobiotic cytochrome P 450s complex leading to decrease the vital functional supply of the malignant compounds. With time, the patient will heal gradually by the welling of god.

The immunity also plays a very important role to accelerate the process of healing. So, the most important thing to feed the immunity is the feeling of care by the patient's family.

The recommended daily allowance of emotional warm care is unlimited.

Claims

Claims

1 - Using of anticoagulant medications, glutathione, and keep the role of cytochrome P450s in the different reactions.

2 - According to claim l ,we may use anticoagulant medication such as warrfarine for the exhaustion of most of cytochrome P450s.

3 - According to claim 2, glutathione concentrated doses will be obligatory for the maintenance of the medical experiment.As it has a role for the excretion of this unwanted complex in urine.